$\textit{Mycobacterium tuberculosis}$ resistance prediction and lineage classification from genome sequencing: comparison of automated analysis tools

Autor: Schleusener, V, Köser, CU, Beckert, P, Niemann, S, Feuerriegel, S

Whole-genome sequencing (WGS) has the potential to accelerate drug-susceptibility testing (DST) to design appropriate regimens for drug-resistant tuberculosis (TB). Several recently developed automated software tools promise to standardize the analys

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71f9526e9ad8ce74bd04d6dd1d877927

Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis.

Autor: Lange, C., Alghamdi, W. A., Al‐Shaer, M. H., Brighenti, S., Diacon, A. H., DiNardo, A. R., Grobbel, H. P., Gröschel, M. I., von Groote‐Bidlingmaier, F., Hauptmann, M., Heyckendorf, J., Köhler, N., Kohl, T. A., Merker, M., Niemann, S., Peloquin, C. A., Reimann, M., Schaible, U. E., Schaub, D., Schleusener, V.

Publikováno v: Journal of Internal Medicine; Aug2018, Vol. 284 Issue 2, p163-188, 26p, 3 Diagrams, 6 Charts, 1 Graph

Revisiting mutational resistance to ampicillin and cefotaxime in Haemophilus influenzae.

Autor: Diricks, Margo^1,2 (AUTHOR), Petersen, Sabine³ (AUTHOR), Bartels, Lennart⁴ (AUTHOR), Lâm, Thiên-Trí⁵ (AUTHOR), Claus, Heike⁵ (AUTHOR), Bajanca-Lavado, Maria Paula⁶ (AUTHOR), Hauswaldt, Susanne⁷ (AUTHOR), Stolze, Ricardo⁴ (AUTHOR), Vázquez, Omar Jiménez¹ (AUTHOR), Utpatel, Christian¹ (AUTHOR), Niemann, Stefan^1,2 (AUTHOR), Rupp, Jan^7,8 (AUTHOR), Wohlers, Inken^4,8 (AUTHOR), Merker, Matthias^2,3 (AUTHOR) mmerker@fz-borstel.de

Publikováno v: Genome Medicine. 12/4/2024, Vol. 16 Issue 1, p1-17. 17p.

Reflex Xpert MTB/XDR Testing of Residual Rifampicin-Resistant Specimens: A Clinical Laboratory-Based Diagnostic Accuracy and Feasibility Study in South Africa.

Autor: Centner, C M^1,2 (AUTHOR), Munir, R³ (AUTHOR), Tagliani, E⁴ (AUTHOR), Rieß, F⁵ (AUTHOR), Brown, P¹ (AUTHOR), Hayes, C⁶ (AUTHOR), Dolby, T⁷ (AUTHOR), Zemanay, W¹ (AUTHOR), Cirillo, D M⁴ (AUTHOR), David, A³ (AUTHOR), Schumacher, S G⁸ (AUTHOR), Denkinger, C M^8,9 (AUTHOR), Ruhwald, M⁸ (AUTHOR), Leukes, V N⁸ (AUTHOR), Nicol, M P¹⁰ (AUTHOR), Walt, I Van der⁶ (AUTHOR), Kisten, G⁷ (AUTHOR), Gumede, M⁷ (AUTHOR), Mace, A⁸ (AUTHOR), Brink, A^1,2,11 (AUTHOR)

Publikováno v: Open Forum Infectious Diseases. Aug2024, Vol. 11 Issue 8, p1-10. 10p.

Reply to Dookie et al., "Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis".

Autor: Köser CU; Department of Genetics, University of Cambridge, Cambridge, United Kingdom.; Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany., Heyckendorf J; Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.; German Center for Infection Research (DZIF), Borstel, Germany.; International Health/Infectious Diseases, University of Lübeck, Lübeck, Germany., Andres S; Division of Mycobacteriology (National Tuberculosis Reference Laboratory), Research Center Borstel, Borstel, Germany., Olaru ID; Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany.; German Center for Infection Research (DZIF), Borstel, Germany., Schön T; Department of Infectious Diseases and Clinical Microbiology, Kalmar County Hospital, Kalmar, Sweden.; Department of Clinical and Experimental Medicine, Division of Medical Microbiology, Linköping University, Linköping, Sweden., Sturegård E; Clinical Microbiology, Department of Translational Medicine, Lund University, Malmö, Sweden., Beckert P; Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.; German Center for Infection Research (DZIF), Borstel, Germany., Schleusener V; Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany., Kohl TA; Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.; German Center for Infection Research (DZIF), Borstel, Germany., Hillemann D; Division of Mycobacteriology (National Tuberculosis Reference Laboratory), Research Center Borstel, Borstel, Germany., Moradigaravand D; Wellcome Trust Sanger Institute, Hinxton, United Kingdom., Parkhill J; Wellcome Trust Sanger Institute, Hinxton, United Kingdom., Peacock SJ; Department of Genetics, University of Cambridge, Cambridge, United Kingdom.; Wellcome Trust Sanger Institute, Hinxton, United Kingdom.; London School of Hygiene & Tropical Medicine, London, United Kingdom., Niemann S; Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.; German Center for Infection Research (DZIF), Borstel, Germany., Lange C; Division of Clinical Infectious Diseases, Research Center Borstel, Borstel, Germany clange@fz-borstel.de.; German Center for Infection Research (DZIF), Borstel, Germany.; International Health/Infectious Diseases, University of Lübeck, Lübeck, Germany.; Department of Medicine, Karolinska Institute, Stockholm, Sweden., Merker M; Molecular and Experimental Mycobacteriology, Research Center Borstel, Borstel, Germany.; German Center for Infection Research (DZIF), Borstel, Germany.

Publikováno v: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2018 Jul 27; Vol. 62 (8). Date of Electronic Publication: 2018 Jul 27 (Print Publication: 2018).